Research Catalog

Improving predictability and transparency in DEA and FDA regulation : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, April 7, 2014.

Title
Improving predictability and transparency in DEA and FDA regulation : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, April 7, 2014.
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health, author.
Publication
Washington : U.S. Government Publishing Office, 2015.

Available Online

https://purl.fdlp.gov/GPO/gpo59306

Details

Description
1 online resource (iv, 217 pages)
Subjects
Genre/Form
Legislative hearings.
Note
  • Title from title screen (viewed on July 24, 2015).
  • Paper version available for sale by the Superintendent of Documents, U.S. Government Publishing Office.
  • "Serial No. 113-147."
Bibliography (note)
  • Includes bibliographical references.
Call Number
GPO Internet Y 4.C 73/8:113-137
OCLC
marcive914355788
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health, author.
Title
Improving predictability and transparency in DEA and FDA regulation : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, April 7, 2014.
Publisher
Washington : U.S. Government Publishing Office, 2015.
Type of Content
text
Type of Medium
computer
Type of Carrier
online resource
Bibliography
Includes bibliographical references.
Connect to:
https://purl.fdlp.gov/GPO/gpo59306
Other Form:
Print version: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health. Improving predictability and transparency in DEA and FDA regulation (OCoLC)917503036 (DLC) 2015461367
Microfiche version: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health. Improving predictability and transparency in DEA and FDA regulation (OCoLC)932070200
Gpo Item No.
1019-C-01 (online)
Sudoc No.
Y 4.C 73/8:113-137
View in Legacy Catalog